trending Market Intelligence /marketintelligence/en/news-insights/trending/cd6qnRTjMjVmZV9iQvFPoA2 content esgSubNav
In This List

OncBioMune Pharmaceuticals names CEO

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


OncBioMune Pharmaceuticals names CEO

OncBioMune Pharmaceuticals Inc. appointed Brian Barnett to replace Jonathan Head as CEO of the company, effective Dec. 26.

Head will continue to serve as OncBioMune's board chairman and was appointed chief scientific officer.

Before joining OncBioMune, Barnett had served at Puma Biotechnology Inc. as vice president and head of medical affairs since August 2016.

Baton Rouge, La.-based OncBioMune Pharmaceuticals is a clinical-stage biopharmaceutical company that develops cancer immunotherapy products.